S
Sanofi
SNYNFCIK 0001121404OTCLarge AcceleratedPharmaceutical PreparationsI0FRFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$7.85B
Total Assets
$126.81B
Equity
—
Shares Out
1.22B
Op. Cash Flow
—
Business
Sanofi is a foreign private issuer in Pharmaceutical Preparations, headquartered in France. Shares trade on Nasdaq under the ticker SNY.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $7.85B |
| Total assets | $126.81B |
| Total liabilities | — |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Holdings (13F)
Portfolio as of 2025-12-31 · 8 positions
Reported AUM
$310.41M
Holdings
8
Top sector
$310.41M
Top sectors
| Sector | Value | % of portfolio |
|---|---|---|
| Uncategorized | $310.41M | 100.0% |
Top holdings
| Issuer | Ticker | Shares | Value | % |
|---|---|---|---|---|
| MeiraGTx Holdings plc | — | 12.20M | $96.97M | 31.2% |
| Inhibrx Biosciences, Inc. | — | 1.16M | $91.48M | 29.5% |
| Novavax | — | 6.88M | $46.24M | 14.9% |
| AnaptysBio | — | 821.9K | $39.85M | 12.8% |
| Immuneering Corp | — | 2.71M | $17.82M | 5.7% |
| MapLight Therapeutics Inc. | — | 912.0K | $16.02M | 5.2% |
| Eledon | — | 815.0K | $1.23M | 0.4% |
| Q32 Bio Inc. | — | 244.1K | $810.0K | 0.3% |